DaVita plays down Ozempic’s potential in treating kidney disease
October 12, 2023 at 12:42 PM EDT
Dialysis company DaVita is not convinced a Novo Nordisk trial's findings relating to its Ozempic treatment will be borne out over time.
Photography by Christophe Tomatis